...
首页> 外文期刊>Vaccine >Development of HSV-specific CD4+ Th1 responses and CD8+ cytotoxic T lymphocytes with antiviral activity by vaccination with the HSV-2 mutant ICP10 triangle PK
【24h】

Development of HSV-specific CD4+ Th1 responses and CD8+ cytotoxic T lymphocytes with antiviral activity by vaccination with the HSV-2 mutant ICP10 triangle PK

机译:通过接种HSV-2突变体ICP10三角PK疫苗开发具有抗病毒活性的HSV特异性CD4 + Th1反应和CD8 +细胞毒性T淋巴细胞

获取原文
获取原文并翻译 | 示例
           

摘要

A growth compromised herpes simplex virus type 2 (HSV-2) mutant which is deleted in the PK domain of the large subunit of ribonucleotide reductase (ICP10DeltaPK) protects from HSV-2 challenge in the mouse and guinea pig cutaneous and vaginal models and reduces the incidence and frequency of recurrent disease (Vaccine (17) (1999) 1951; Vaccine (19) (2001) 1879). The present studies were designed to identify the immune responses induced by ICP10DeltaPK and define the component responsible for protective activity. We found that ICP10DeltaPK elicits a predominant HSV-specific T helper type 1 (Th1) response, as evidenced by: (1) higher levels of HSV-specific IgG2a (Th1) than IgG1 (Th2) isotypes and (2) higher numbers of CD4+ IFN-gamma than IL-10 secreting T cells in popliteal lymph nodes. This Th1 response pattern was associated with a significant increase in the levels of IL-12 produced by dendritic cells from ICP10DeltaPK than HSV-2 immunized animals. Lymph node cells (LNCs) from ICP10DeltaPK immunized mice had significantly higher levels of HSV-2 specific cytolytic activity than LNCs from mice immunized with HSV-2 and it was mediated by CD8+ T cells. CD8+ CTL were not seen in LNCs from HSV-2 immunized mice. In adoptive transfer experiments, CD8+ T cells and, to a lower extent, CD4+ T cells from ICP10DeltaPK immunized mice inhibited HSV-2 replication, suggesting that they are involved in the protective immunity induced by ICP10DeltaPK vaccination. (C) 2002 Elsevier Science Ltd. All rights reserved. [References: 90]
机译:在核糖核苷酸还原酶大亚基的PK结构域(ICP10DeltaPK)中缺失的生长受损的2型单纯疱疹病毒2型(HSV-2)突变体可在小鼠和豚鼠的皮肤和阴道模型中保护免受HSV-2攻击并降低发病率和复发率(Vaccine(17)(1999)1951; Vaccine(19)(2001)1879)。本研究旨在确定由ICP10DeltaPK诱导的免疫应答,并确定负责保护活性的成分。我们发现ICP10DeltaPK引发了主要的HSV特异性T辅助型1(Th1)反应,这可以通过以下方面证明:(1)HSV特异性IgG2a(Th1)的水平高于IgG1(Th2)的同种型,以及(2)更高的CD4 + pop淋巴结中的IFN-γ比IL-10分泌性T细胞高。这种Th1反应模式与ICP10DeltaPK的树突状细胞相比HSV-2免疫动物的IL-12水平显着增加有关。 ICP10DeltaPK免疫小鼠的淋巴结细胞(LNC)的HSV-2特异性溶细胞活性比HSV-2免疫小鼠的LNC显着高,并且它是由CD8 + T细胞介导的。在来自HSV-2免疫小鼠的LNC中未观察到CD8 + CTL。在过继转移实验中,来自ICP10DeltaPK免疫小鼠的CD8 + T细胞和较低程度的CD4 + T细胞抑制HSV-2复制,表明它们参与了ICP10DeltaPK疫苗诱导的保护性免疫。 (C)2002 Elsevier ScienceLtd。保留所有权利。 [参考:90]

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号